Clinical Trial

A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)

Name: A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) — clinical trial record (NCT07633197)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the safety and tolerability of different dosages of recombinant zoster vaccine (CHO cell) when administered to adults aged 40 years and older.

Trial Details

NCT Number	NCT07633197
Lead Sponsor	Changchun BCHT Biotechnology Co.
Conditions	Herpes
Enrollment	120 participants
Start Date	2026-05-28
Primary Completion	2026-12-28 (estimated)
Study Completion	2027-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-08